glaxo aims profit
glaxosmithkline profits drugmaker recovery
cheap drugs paxil wellbutrin weak dollar profits confident drug pipeline profits failure obesity drug garnier
afternoon pence garnier absorbed generics managing pipeline discontinued experimental treatment obesity disappointing clinical glaxo relying treatments cancer diabetes depression allergies lift pace disappointing
